Lymphocyte subset distribution can predict the efficacy of first-line treatment in patients with non-Hodgkin lymphoma. Clinical Medicine and Pharmacology, [S. l.], v. 3, n. 1, 2026. DOI: 10.70731/1m330584. Disponível em: https://jandoopress.com/journal/cmp/article/view/212. Acesso em: 16 jun. 2026.